Instituto Pedro Nunes
IPN     IPN Incubadora

eMAPS 3
Market Access for Partners

Challenge

eMAPS 3 targets entrepreneurs, innovators, SMEs and others in the life science sector. Gives entrepreneurs and SMEs access to practical knowledge that can be applied to gain market access, allowing them to bring products to market in a sustainable and cost-effective way. Through this platform aims to accelerate innovation adoption to improve the health of European citizens. eMAPS 3 covers the area of the drugs and biotech products; medical devices and diagnostics; and digital health solutions.

Solution

The eMAPs platform is an innovative learning portal to support entrepreneurs and innovators to navigate the complex processes and pathways involved in accessing healthcare markets (drugs and biotech products; medical devices and diagnostics; and digital health solutions) across Europe. The eMAPS 3 proposal will further develop the platform by adding much needed information on Germany, Italy and Portugal as well as the US.

Project Reference

19113

Funding

EIT Health
EIT Health

Location

Europe

Total Cost

614.339.00

IPN Cost

614.339.00

EU financial support

614.339.00

National public financial support

60.000.00

Duration

12 meses

Consortium

0005 - Achmea Zorgverzekeringen NV.
0013 - Friedrich-Alexander-Universität Erlangen-Nürnberg
0013-1 - Universitätsklinikum Erlangen
0091 - Instituto Pedro Nunes
0108 - Oxford University Hospitals NHS Foundation Trust
0152 - Universitá degli Studi Di Napoli Federico II (Unina)

Partners

 

Website

https://clinicalinnovation.org.uk/project/emaps-knowledge-hub-industry-clinical-innovators/

Keywords

Drugs and biotech products; medical devices and diagnostics; and digital health solutions